vimarsana.com

Page 38 - தடுப்பூசி விநியோகி நுழைவு உத்தரவாதம் சிறப்பு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Malaysia may add Johnson & Johnson to its vaccine armoury

PUTRAJAYA: Malaysia looks set to add Johnson & Johnson to its lineup of Covid-19 vaccine suppliers, in a boost to the country’s National Covid-19 Immunisation Programme. Science, Technology and Innovation Minister Khairy Jamaluddin said the government is in discussions with the US multinational to finalise the procurement of its vaccine. “The Cabinet has given its approval for the procurement of the Johnson & Johnson vaccine, following a recommendation by the Covid-19 Vaccine Supply Access Guarantee Special Committee. “Among the reasons for this decision is that it is a single-dose vaccine and that the clinical information on it has appeared positive so far.

Covid-19: J&J vaccine more attractive due to one dose, says Dr Adham Baba | Malaysia

PUTRAJAYA, Feb 18 Malaysia finds the Johnson & Johnson Covid-19 vaccine more attractive as recipients need to take only one dose, said Health Minister Datuk Seri Dr Adham Baba. “The Johnson & Johnson vaccine uses a one-dose method and thus makes it very attractive to use,” he told.

J&J vaccine more attractive due to one dose - Health Minister (Updated)

18 Feb 2021 / 18:52 H. Pix for illustration purposes. PUTRAJAYA: Malaysia finds the Johnson & Johnson Covid-19 vaccine more attractive as recipients need to take only one dose, said Health Minister Datuk Seri Dr Adham Baba. “The Johnson & Johnson vaccine uses a one-dose method and thus makes it very attractive to use,“ he told reporters after receiving a donation of 2.7 million low dead-volume syringes worth RM891,000 from Etiqa Family Takaful Berhad at his ministry here today. On Wednesday, Minister of Science, Technology and Innovation Khairy Jamaluddin had announced that the government will sign a Covid-19 vaccine procurement contract with Johnson & Johnson from the United States soon.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.